MoneyWorks4Me

The quarter ended June 2025 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1540.67 millions.A slim rise of 16.91% was recorded in the Net profit for the quarter ended June 2025 to Rs. 276.75  millions  From Rs. 236.72 millions.Operating Profit saw a handsome growth to 390.76 millions from 331.41 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1540.67 1472.82 4.61 1540.67 1472.82 4.61 6232.30 5805.50 7.35
Other Income 152.72 104.09 46.72 152.72 104.09 46.72 224.77 344.22 -34.70
PBIDT 390.76 331.41 17.91 390.76 331.41 17.91 1239.71 1343.30 -7.71
Interest 2.10 4.39 -52.16 2.10 4.39 -52.16 18.83 14.63 28.71
PBDT 388.66 327.02 18.85 388.66 327.02 18.85 1220.88 1328.67 -8.11
Depreciation 34.77 32.24 7.85 34.77 32.24 7.85 128.99 106.25 21.40
PBT 353.89 294.78 20.05 353.89 294.78 20.05 1091.89 1222.42 -10.68
TAX 77.14 58.06 32.86 77.14 58.06 32.86 268.42 289.38 -7.24
Deferred Tax 35.91 2.93 1125.60 35.91 2.93 1125.60 15.15 34.95 -56.65
PAT 276.75 236.72 16.91 276.75 236.72 16.91 823.47 933.04 -11.74
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 25.36 22.50 12.72 25.36 22.50 12.72 19.89 23.14 -14.03

Lincoln Pharma Share Price

620.40 8.50 (1.39%)
25-Aug-2026 13:31 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1905.75
Dr. Reddys Labs. 1182.35
Cipla 1418.00
Lupin 2174.00
Zydus Lifesciences 1110.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: